tiprankstipranks
Trending News
More News >
Roche Holding Ltd (CH:RO)
:RO
Switzerland Market
Advertisement

Roche Holding Ltd (RO) Price & Analysis

Compare
3 Followers

RO Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.47%<0.01%94.31%
Insiders
1.47%
Mutual Funds
<0.01% Other Institutional Investors
94.31% Public Companies and
Individual Investors

RO FAQ

What was Roche Holding Ltd’s price range in the past 12 months?
Roche Holding Ltd lowest stock price was CHF244.00 and its highest was CHF333.60 in the past 12 months.
    What is Roche Holding Ltd’s market cap?
    Roche Holding Ltd’s market cap is CHF206.71B.
      When is Roche Holding Ltd’s upcoming earnings report date?
      Roche Holding Ltd’s upcoming earnings report date is Jul 24, 2025 which is in 5 days.
        How were Roche Holding Ltd’s earnings last quarter?
        Roche Holding Ltd released its earnings results on Jan 30, 2025. The company reported CHF8.57 earnings per share for the quarter, beating the consensus estimate of CHF8.12 by CHF0.45.
          Is Roche Holding Ltd overvalued?
          According to Wall Street analysts Roche Holding Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Roche Holding Ltd pay dividends?
            Roche Holding Ltd pays a Annually dividend of CHF9.7 which represents an annual dividend yield of 3.57%. See more information on Roche Holding Ltd dividends here
              What is Roche Holding Ltd’s EPS estimate?
              Roche Holding Ltd’s EPS estimate is 10.77.
                How many shares outstanding does Roche Holding Ltd have?
                Roche Holding Ltd has 106,691,000 shares outstanding.
                  What happened to Roche Holding Ltd’s price movement after its last earnings report?
                  Roche Holding Ltd reported an EPS of CHF8.57 in its last earnings report, beating expectations of CHF8.12. Following the earnings report the stock price went up 1.536%.
                    Which hedge fund is a major shareholder of Roche Holding Ltd?
                    Currently, no hedge funds are holding shares in CH:RO

                    Company Description

                    Roche Holding Ltd

                    Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Novartis AG
                    Lonza Group Ltd
                    Straumann Holding AG
                    Alcon
                    Galderma Group AG
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis